CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -85.7% | 239 | -89.4% | 0.00% | – |
| Q4 2021 | $7,000 | -22.2% | 2,264 | -14.7% | 0.00% | – |
| Q3 2021 | $9,000 | -18.2% | 2,653 | -0.1% | 0.00% | – |
| Q2 2021 | $11,000 | +450.0% | 2,656 | +2131.9% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 119 | +29.3% | 0.00% | – |
| Q3 2020 | $1,000 | -96.6% | 92 | -96.8% | 0.00% | – |
| Q2 2020 | $29,000 | +93.3% | 2,901 | +181.7% | 0.00% | – |
| Q3 2018 | $15,000 | -97.3% | 1,030 | -96.9% | 0.00% | -100.0% |
| Q2 2018 | $560,000 | -25.5% | 33,261 | +1.3% | 0.00% | 0.0% |
| Q1 2018 | $752,000 | +32.6% | 32,821 | +49.7% | 0.00% | 0.0% |
| Q4 2017 | $567,000 | +18800.0% | 21,923 | +10861.5% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 200 | +78.6% | 0.00% | – |
| Q4 2015 | $2,000 | -81.8% | 112 | -84.2% | 0.00% | – |
| Q2 2015 | $11,000 | 0.0% | 709 | 0.0% | 0.00% | – |
| Q1 2015 | $11,000 | 0.0% | 709 | -14.1% | 0.00% | – |
| Q4 2014 | $11,000 | – | 825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |